New research suggests that regular aerobic exercise doesn’t just benefit the heart muscle, but subtly rewires the nerves that control how the heart works. Regular physical activity does more than ...
FDA approved CYTK's Myqorzo for oHCM. It reduces heart's pumping ability, has a warning for heart failure and expected to ...
The US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM ...
Final Decision from European Commission Expected in Q1 2026SOUTH SAN FRANCISCO, Calif., (GLOBE NEWSWIRE) -- Cytokinetics, ...
Final Decision from European Commission Expected in Q1 2026 SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Committee ...
Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of death worldwide, accounting for over three million deaths each year, according to the World Health Organization. Given ...
Among those with abnormal breathlessness at peak exercise, 55% to 60% displayed normal breathlessness across all submaximal exercise intensities. Abnormally high breathlessness among middle-age and ...
ABSTRACT: Background: Among cardiopulmonary exercise testing (CPET) variables, maximum oxygen uptake (VO2max) and ventilatory efficiency (VE/VCO2 slope) are frequently used predictive indices for ...
ABSTRACT: Background: Among cardiopulmonary exercise testing (CPET) variables, maximum oxygen uptake (VO2max) and ventilatory efficiency (VE/VCO2 slope) are frequently used predictive indices for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback